Established in 2012, OncoCard Hospital is based on an innovative concept of integrative medicine that starts from the diagnosis phase of the oncological patient and covers the entire period of specific active therapies. The medical unit includes ambulatory, oncology surgery, hematology, radiotherapy and medical imaging departments, as well as its own laboratory, used internally for inpatients. From the opening of the hospital to date, investments of EUR24 million have been made. In 2018, the company recorded a consolidated turnover of RON41.8 million.
“This partnership follows our strategy to expand and develop the segment of oncological services and we are pleased to have with us a team of experts who will further strengthen the area of medical excellence. OncoCard complements the oncology services that we already provide to patients, in the surgical departments of all MedLife hospitals, and becomes the first integrated oncological center at Brasov level and the second at group level, after Sibiu. Through the values that bring us together, I am confident that joining OncoCard will contribute to strengthening our position as a national leader in medical services. It is an area of interest for us and we do not exclude that in the coming years we will invest consistently in the oncological treatment of excellence at national level,” said Mihai Marcu, President and CEO MedLife.
MedLife reported a net profit of RON5.7 million in January-September 2019, up 134.6% from the year-earlier period, and a turnover of RON336.6 million, up 7.8% on the year.
The transaction is pending the approval of Romania’s Competition Council. Once approved, it may become the most important transaction of MedLife group in 2019, representing an important step in fulfilling the company’s commitment to shareholders and customers.
“We have always advocated for excellence in health, proposing that we become a standard of quality at the level of the medical services we offer, thus managing to instill confidence and courage in our patients. These characteristics are reconfirmed to us today through the partnership with the leader of the private medicine in Romania, which only enjoys and honors us equally. And more than that, we aim to be better and better in the fight against disease, cancer screening and treatment”, said Raluca Butuza, OncoCard Brașov shareholder.
By taking over OncoCard Hospital, MedLife group reaches a portfolio of 27 acquired companies, the last one announced being the Micromedica Medical Center.
The cancer hospital in Brasov was established by the company Onco Card Invest in 2012, following an investment of EUR24 million, carried out by five local entrepreneurs.